Cargando…

Prediction of pathological complete response and prognosis in patients with neoadjuvant treatment for triple-negative breast cancer

BACKGROUND: It has been reported that pathological complete response is an important surrogate marker for disease-free survival and overall survival in patients with triple-negative breast cancer. This study investigates predictors of the response to neoadjuvant platinum-based or anthracycline-based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gass, Paul, Lux, Michael P., Rauh, Claudia, Hein, Alexander, Bani, Mayada R., Fiessler, Cornelia, Hartmann, Arndt, Häberle, Lothar, Pretscher, Jutta, Erber, Ramona, Wachter, David L., Schulz-Wendtland, Rüdiger, Beckmann, Matthias W., Fasching, Peter A., Wunderle, Marius
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6206705/ https://www.ncbi.nlm.nih.gov/pubmed/30373556 http://dx.doi.org/10.1186/s12885-018-4925-1

Ejemplares similares

HLA-G and HLA-F protein isoform expression in breast cancer patients receiving neoadjuvant treatment
por: Wuerfel, Franziska M., et al.
Publicado: (2020)

Risk, Prediction and Prevention of Hereditary Breast Cancer – Large-Scale Genomic Studies in Times of Big and Smart Data
por: Wunderle, Marius, et al.
Publicado: (2018)

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment
por: Fasching, Peter A, et al.
Publicado: (2011)

PIWI-Like 1 and PIWI-Like 2 Expression in Breast Cancer
por: Erber, Ramona, et al.
Publicado: (2020)

Mammographic density and prognosis in primary breast cancer patients
por: Heindl, Felix, et al.
Publicado: (2021)

Expression of the Immunohistochemical Markers CK5, CD117, and EGFR in Molecular Subtypes of Breast Cancer Correlated with Prognosis
por: Schulmeyer, Carla E., et al.
Publicado: (2023)

Variable Expression of the Disialoganglioside GD2 in Breast Cancer Molecular Subtypes
por: Erber, Ramona, et al.
Publicado: (2021)

Impact of fibroblast growth factor receptor 1 (FGFR1) amplification on the prognosis of breast cancer patients
por: Erber, Ramona, et al.
Publicado: (2020)

Cost effectiveness of bilateral risk-reducing mastectomy and salpingo-oophorectomy
por: Schrauder, Michael G., et al.
Publicado: (2019)

Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients
por: Hein, Alexander, et al.
Publicado: (2014)

Using Probability for Pathological Complete Response (pCR) as a Decision Support Marker for Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Patients – a Survey Among Physicians
por: Gass, Paul, et al.
Publicado: (2018)

Clinical Characteristics and Prognosis of HER2-0 and HER2-Low-Positive Breast Cancer Patients: Real-World Data from Patients Treated with Neoadjuvant Chemotherapy
por: Pöschke, Patrik, et al.
Publicado: (2023)

Circulating Micro-RNAs as Potential Blood-Based Markers for Early Stage Breast Cancer Detection
por: Schrauder, Michael G., et al.
Publicado: (2012)

Predicting mammographic density with linear ultrasound transducers
por: Behrens, Annika, et al.
Publicado: (2023)

Using automated texture features to determine the probability for masking of a tumor on mammography, but not ultrasound
por: Häberle, Lothar, et al.
Publicado: (2017)

Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center
por: Loehberg, Christian R., et al.
Publicado: (2020)

RANKL and OPG and their influence on breast volume changes during pregnancy in healthy women
por: Wunderle, Marius, et al.
Publicado: (2020)

Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setup
por: Emons, Julius, et al.
Publicado: (2020)

Addition of triple negativity of breast cancer as an indicator for germline mutations in predisposing genes increases sensitivity of clinical selection criteria
por: Hoyer, Juliane, et al.
Publicado: (2018)

Fine needle aspiration cytology of lymph nodes in breast cancer follow-up is a feasible alternative to watchful waiting and to histology
por: Hammon, Matthias, et al.
Publicado: (2015)

Breast Tumor Analysis Using Shifted-Excitation Raman Difference Spectroscopy (SERDS)
por: Gebrekidan, Medhanie Tesfay, et al.
Publicado: (2018)

Endometriosis as a risk factor for ovarian or endometrial cancer — results of a hospital-based case–control study
por: Burghaus, Stefanie, et al.
Publicado: (2015)

Galactography with Tomosynthesis Technique (Galactomosynthesis) – Renaissance of a Method?
por: Schulz-Wendtland, Rüdiger, et al.
Publicado: (2018)

Characterizing mammographic images by using generic texture features
por: Häberle, Lothar, et al.
Publicado: (2012)

Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma
por: Wachter, David L., et al.
Publicado: (2014)

FemZone trial: a randomized phase II trial comparing neoadjuvant letrozole and zoledronic acid with letrozole in primary breast cancer patients
por: Fasching, Peter A, et al.
Publicado: (2014)

Filtration based assessment of CTCs and CellSearch® based assessment are both powerful predictors of prognosis for metastatic breast cancer patients
por: Huebner, Hanna, et al.
Publicado: (2018)

Targeted sequencing of FH-deficient uterine leiomyomas reveals biallelic inactivating somatic fumarase variants and allows characterization of missense variants
por: Popp, Bernt, et al.
Publicado: (2020)

Prominent entrapment of respiratory epithelium in primary and metastatic intrapulmonary non-epithelial neoplasms: a frequent morphological pattern closely mimicking adenofibroma and other biphasic pulmonary lesions
por: Erber, Ramona, et al.
Publicado: (2020)

Molecular Subtyping of Invasive Breast Cancer Using a PAM50-Based Multigene Expression Test-Comparison with Molecular-Like Subtyping by Tumor Grade/Immunohistochemistry and Influence on Oncologist’s Decision on Systemic Therapy in a Real-World Setting
por: Erber, Ramona, et al.
Publicado: (2022)

Correlation of mammographic density and serum calcium levels in patients with primary breast cancer
por: Hack, Carolin C., et al.
Publicado: (2017)

Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases
por: Lux, Michael P., et al.
Publicado: (2015)

Implementation of machine learning into clinical breast MRI: Potential for objective and accurate decision-making in suspicious breast masses
por: Ellmann, Stephan, et al.
Publicado: (2020)

Effect of Premature Rupture of Membranes on Induction of Labor: A Historical Cohort Study
por: Kehl, Sven, et al.
Publicado: (2017)

Induction of labour with sequential double-balloon catheter and oral misoprostol versus oral misoprostol alone in obese women
por: Kehl, Sven, et al.
Publicado: (2019)

The Chorioallantoic Membrane Xenograft Assay as a Reliable Model for Investigating the Biology of Breast Cancer
por: Ranjan, Raphela A., et al.
Publicado: (2023)

Improving the Quality of Care for Cancer Patients through Oncological Second Opinions in a Comprehensive Cancer Center: Feasibility of Patient-Initiated Second Opinions through a Health-Insurance Service Point
por: Schulmeyer, Carla E., et al.
Publicado: (2023)

DICER1-Mutated Botryoid Fibroepithelial Polyp of the Parotid Duct: Report of the First Case
por: Erber, Ramona, et al.
Publicado: (2021)

Tumour-Infiltrating Inflammatory Cells in Early Breast Cancer: An Underrated Prognostic and Predictive Factor?
por: Schnellhardt, Sören, et al.
Publicado: (2020)

Accelerated Partial Breast Irradiation: Macrophage Polarisation Shift Classification Identifies High-Risk Tumours in Early Hormone Receptor-Positive Breast Cancer
por: Schnellhardt, Sören, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ma1342sp50t58q3dcmpc4kjpln